686 related articles for article (PubMed ID: 26628089)
1. How to make an oligodendrocyte.
Goldman SA; Kuypers NJ
Development; 2015 Dec; 142(23):3983-95. PubMed ID: 26628089
[TBL] [Abstract][Full Text] [Related]
2. Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells.
Terzic D; Maxon JR; Krevitt L; DiBartolomeo C; Goyal T; Low WC; Dutton JR; Parr AM
Cell Transplant; 2016; 25(2):411-24. PubMed ID: 25955415
[TBL] [Abstract][Full Text] [Related]
3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
[TBL] [Abstract][Full Text] [Related]
5. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
6. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.
Liu S; Qu Y; Stewart TJ; Howard MJ; Chakrabortty S; Holekamp TF; McDonald JW
Proc Natl Acad Sci U S A; 2000 May; 97(11):6126-31. PubMed ID: 10823956
[TBL] [Abstract][Full Text] [Related]
8. Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro.
Namchaiw P; Wen H; Mayrhofer F; Chechneva O; Biswas S; Deng W
Stem Cell Res Ther; 2019 Aug; 10(1):272. PubMed ID: 31455382
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.
Alizadeh A; Karimi-Abdolrezaee S
J Physiol; 2016 Jul; 594(13):3539-52. PubMed ID: 26857216
[TBL] [Abstract][Full Text] [Related]
10. Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies.
McCaughey-Chapman A; Connor B
J Neurosci Res; 2023 Jun; 101(6):1000-1028. PubMed ID: 36749877
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of remyelination: recent insight from experimental models.
Tanaka T; Yoshida S
Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
[TBL] [Abstract][Full Text] [Related]
12. Dorsally-derived oligodendrocytes in the spinal cord contribute to axonal myelination during development and remyelination following focal demyelination.
Zhu Q; Whittemore SR; Devries WH; Zhao X; Kuypers NJ; Qiu M
Glia; 2011 Nov; 59(11):1612-21. PubMed ID: 21710609
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Mei F; Mayoral SR; Nobuta H; Wang F; Desponts C; Lorrain DS; Xiao L; Green AJ; Rowitch D; Whistler J; Chan JR
J Neurosci; 2016 Jul; 36(30):7925-35. PubMed ID: 27466337
[TBL] [Abstract][Full Text] [Related]
14. Cells of the oligodendroglial lineage, myelination, and remyelination.
Miron VE; Kuhlmann T; Antel JP
Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
[TBL] [Abstract][Full Text] [Related]
15. Derivation of high-purity oligodendroglial progenitors.
Hatch MN; Nistor G; Keirstead HS
Methods Mol Biol; 2009; 549():59-75. PubMed ID: 19378196
[TBL] [Abstract][Full Text] [Related]
16. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
Mothe AJ; Tator CH
Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
[TBL] [Abstract][Full Text] [Related]
17. Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells.
Yun W; Hong W; Son D; Liu HW; Kim SS; Park M; Kim IY; Kim DS; Song G; You S
Stem Cells Dev; 2019 May; 28(10):633-648. PubMed ID: 30880587
[TBL] [Abstract][Full Text] [Related]
18. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
Kawabata S; Takano M; Numasawa-Kuroiwa Y; Itakura G; Kobayashi Y; Nishiyama Y; Sugai K; Nishimura S; Iwai H; Isoda M; Shibata S; Kohyama J; Iwanami A; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Jan; 6(1):1-8. PubMed ID: 26724902
[TBL] [Abstract][Full Text] [Related]
19. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation.
Wang Y; Piao JH; Larsen EC; Kondo Y; Duncan ID
J Neurosci Res; 2011 Nov; 89(11):1737-46. PubMed ID: 21793039
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy.
Sher F; Balasubramaniyan V; Boddeke E; Copray S
Curr Opin Neurol; 2008 Oct; 21(5):607-14. PubMed ID: 18769257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
